title: Congenital cytomegalovirus infection.
abstract: OBJECTIVE
  Congenital cytomegalovirus is the most common viral infection affecting approximately 1% of newborns. The virus can be transmitted to the fetus during both primary and recurrent infection. Although most of the infants are asymptomatic at birth, up to 15% develop late complications. The annual cost of treating cytomegalovirus infection complications in the USA is two billion US dollars. Many issues regarding cytomegalovirus infection such as routine screening, antenatal diagnosis and vaccination during pregnancy are unsettled and disputed. The aim of this article is to review the current literature on the subject and to draw some conclusions.
  
  
  METHODS
  Review of the current literature.
  
  
  CONCLUSIONS
  At present, it appears that there is no indication for routine prenatal screening, while other issues, such as the most accurate method for antenatal diagnosis and the indications for pregnancy termination are, as yet, unsettled.
authors.affiliation: Department of Obstetrics and Gynecology A, Tel Aviv Sourasky Medical Center, Israel.
authors.forename: Y
authors.initials: Y
authors.lastname: Daniel
authors.forename: I
authors.initials: I
authors.lastname: Gull
authors.forename: M R
authors.initials: MR
authors.lastname: Peyser
authors.forename: J B
authors.initials: JB
authors.lastname: Lessing
mesh_terms: D003586:Cytomegalovirus Infections / Q000150:complications / Q000151:congenital* / Q000175:diagnosis / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011296:Prenatal Diagnosis; D014481:United States; D014765:Viral Vaccines
chemical_list: D014765:Viral Vaccines